The Burrill Report

The Burrill Report (February 20, 2012): Will Obama's Budget Hinder Innovation? (.MP3,15.66 Mb)

President Obama proposed budget for fiscal 2013 created concerns among researchers, the pharmaceutical industry, and patient advocates. Under it, NIH funding would remain flat, industry would shoulder a greater share of FDA’s expenses, and pharmaceutical companies would kick in an additional $156 billion in Medicare Part D rebates over the next 10 years. We spoke to Margaret Anderson, executive director of FasterCures, about the President's proposed budget, what it means for research and development, and what can be done to ensure pressure to cut spending doesn’t hinder innovation.

February 17, 2012
http://www.burrillreport.com/article-will_obamas_budget_hinder_innovation.html